Dáil Éireann Debate, Tuesday - 12 June 2018
581. Deputy Clare Daly asked the Minister for Health further to Parliamentary Question No. 132 of 24 May 2018, the exact quantum of funding allocated in 2018 to provide for the full implementation of national policies and guidelines in regard to antimicrobial resistance and healthcare acquired infections. [24236/18]
Amharc ar fhreagraFollowing on from the answer to Parliamentary Question No. 132 of 24 May 2018, the Department in recognising the challenges of CPE for the health system held back dedicated funding for 2018. The HSE is prioritising work programmes for this funding in line with CPE risk.
The funding held back provides for a full year cost of €2 million for healthcare associated infection and antimicrobial resistance.
The need for on-going assessment of additional resources to address the challenges of drug resistant organisms for the next number of years is recognised by both the Department and the HSE. This will form part of the estimates process and service planning for 2019 and beyond.
